Myriad Genetics, Inc. · NASDAQ:MYGN
Barclays PLC reported a 5.31% stake in Myriad Genetics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 12, 2025
Barclays PLC reported a 5.31% stake in Myriad Genetics, Inc., 4,899,951 shares, as a passive investor on Jun 30, 2025. Filed Aug 12, 2025 (Schedule 13G).
- Stake
- 5.31%
- Shares
- 4,899,951
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Barclays PLC | 5.31% | 4,899,951 |
Source
Related
- Myriad Genetics, Inc.
- Barclays PLC
- Myriad Genetics, Inc. shareholders
- Schedule 13G/A · Barclays PLC · Nov 12, 2025
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026